Varex Imaging Expects Q3 Revenues Of $200M-$220M (Est $224.50M), Adj EPS Of $0.05-$0.25 (Est $0.33)
$VREX
Industrial Machinery/Components
Technology
Varex Imaging Expects Q3 Revenues Of $200M-$220M (Est $224.50M), Adj EPS Of $0.05-$0.25 (Est $0.33)
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/23/2024 | $21.00 | Buy | B. Riley Securities |
| 10/12/2022 | $24.00 | Hold | Jefferies |
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary Revenues of $200 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating margin 6% | Non-GAAP operating margin* 7% GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.07 per diluted share Cash flow from operations was $10 million Sunny Sanyal, Chief Executive Officer, stated, "Demand in the first quarter was solid, with both Medical and Industrial revenue up year-over-year. Favorable sales mix and productivity gains across both segments resulted in higher than expected profitability and earnings
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, February 6, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 6th thr
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2024. Q4 FY24 Summary Revenues of $206 million GAAP gross margin 33% | Non-GAAP gross margin* 33% GAAP operating expense $56 million | Non-GAAP operating expense* $53 million GAAP operating margin 5% | Non-GAAP operating margin* 7% GAAP net earnings $(1.22) per diluted share | Non-GAAP net earnings* $0.19 per diluted share Cash flow from operations $26 million FY24 Summary Revenues of $811 million GAAP gross margin 32% | Non-GAAP gross margin* 32% GAAP operating expense $225 million | Non-GAAP operating expense* $210 million GAAP o
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary Revenues of $200 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating margin 6% | Non-GAAP operating margin* 7% GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.07 per diluted share Cash flow from operations was $10 million Sunny Sanyal, Chief Executive Officer, stated, "Demand in the first quarter was solid, with both Medical and Industrial revenue up year-over-year. Favorable sales mix and productivity gains across both segments resulted in higher than expected profitability and earnings
Varex Imaging Corporation (NASDAQ:VREX) today announced that it has received orders for non-intrusive cargo inspection systems valued at approximately $14 million USD. The orders are for the recently launched high energy inspection systems, VXP-6 Portal and VXM-6 Mobile systems for cargo and vehicle inspection, which are designed to assist in securing ports and borders. Varex Imaging CEO, Sunny Sanyal, stated, "We are excited to see the interest and adoption in the newly launched product line of full screening systems." Sanyal added, "Our reputation in high energy linear accelerators enables us to engage with end-users and strengthen our portfolio of offerings to our customers to help sec
Varex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to participate in the following upcoming investor conferences. BTIG at Snowbird: The 12th Annual MedTech, Digital Health, LS&D Tools Conference in Salt Lake City, UT – Wednesday, February 12, 2025 (1x1 meetings only) B. Riley Securities Precision Oncology & Radiopharma Conference – Friday, February 28, 2025 in New York, NY (1x1 meetings only) About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
B. Riley Securities initiated coverage of Varex Imaging with a rating of Buy and set a new price target of $21.00
Jefferies initiated coverage of Varex Imaging with a rating of Hold and set a new price target of $24.00
Oppenheimer upgraded Varex Imaging from Market Perform to Outperform and set a new price target of $35.50
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
SCHEDULE 13G/A - Varex Imaging Corp (0001681622) (Subject)
10-Q - Varex Imaging Corp (0001681622) (Filer)
8-K - Varex Imaging Corp (0001681622) (Filer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)